Search Results - Macaraeg, Meghan

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies

    Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hem... by DiNardo, Courtney D., Savona, Michael R., Kishtagari, Ashwin, Fathi, Amir T., Bhalla, Kapil N., Agresta, Samuel, Reilly, Sarah, Almon, Caroline, Hentemann, Murphy, Hickman, Denice, Corrigan, Dillon, Macaraeg, Meghan, Piel, Jessica, Horrigan, Kim, Nabhan, Salah, Martin, Paul, Stein, Eytan M.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Full Doses of Crenolanib, a Type I FLT3 Inhibitor, Can be Safely Administered in AML Patients Post Allogeneic Stem Cell Transplant

    Full Doses of Crenolanib, a Type I FLT3 Inhibitor, Can be Safely Administered in AML Patients Post Allogeneic Stem Cell Transplant by Collins, Robert, Kantarjian, Hagop M., Ravandi, Farhad, Chen, Jenny, Macaraeg, Meghan, Urity, Vinoo, Pond, Blake, Ramachandran, Abhijit, Cortes, Jorge E.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Population Pharmacokinetics of Crenolanib, a Type I FLT3 Inhibitor, in Patients with Relapsed/Refractory AML

    Population Pharmacokinetics of Crenolanib, a Type I FLT3 Inhibitor, in Patients with Relapsed/Refractory AML by Panetta, John Carl, Baker, Sharyn D, Kantarjian, Hagop M., Stewart, Clinton, Pond, Blake, Macaraeg, Meghan, Makinde, Tolu, Vali, Sheetal, Daver, Naval, Ramachandran, Abhijit, Collins, Robert, Cortes, Jorge E.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: